Parmax Pharma Ltd SHARE PRICE [LIVE]

BSE: INE240T01014 NSE: PARMAX SECTOR: Pharma

Buy Sell

NSE

N/A

Change:

BSE

28.70

Change:

NSE

BSE Click here to view BSE data

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Open:
High:
Low:

MKT Cap:
52-wk High:
52-wk Low:

Prev close:
P/E:
Div yield:

5 MIN 10 MIN 15 MIN 30 MIN 60 MIN 2 HR 1 D 1 WK 1 M

NEUTRAL

PARMAX

Fundamental analysis

What is not working for the company?

Stock

Sector

Sensex

Name	Mar 21	Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Parmax Pharma Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

PARMAX News

Frequently Asked Questions

What is the Share price of Parmax Pharma Ltd (PARMAX)?

Parmax Pharma Ltd (PARMAX) share price as of August 12, 2022, on BSE is Rs 28.70 (BSE).

Can I buy Parmax Pharma Ltd (PARMAX) shares?

Yes, You can buy Parmax Pharma Ltd (PARMAX) shares by opening a Demat account with Angel One.

How do I buy Parmax Pharma Ltd (PARMAX) from Angel One?

Parmax Pharma Ltd (PARMAX) share can be brought through the following modes:

Direct investment: You can buy Parmax Pharma Ltd (PARMAX) shares by opening a Demat account with Angel One.
Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Parmax Pharma Ltd (PARMAX) shares.

In which sector do Parmax Pharma Ltd (PARMAX) belong?

Parmax Pharma Ltd (PARMAX) belongs to Pharma.

About PARMAX

Today's live share price for Parmax Pharma Ltd is NSE: N/A, BSE: ₹ 28.70 with a current market capitalization of .

Incorporated as a public limited company in Nov.'94, Parmax Pharma (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. PPL set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 tpa. Its Antibiotic project has been fully implemented from 31st May'97, and the non-Antibiotic products project is under final stage of implementation.